Multiple Myeloma Breakthroughs: The Promise of CD38-Directed Approaches
Multiple Myeloma Breakthroughs: The Promise of CD38-Directed Approaches Multiple Myeloma, a blood cancer originating in the plasma cells of the bone marrow, continues to be a significant challenge in oncology. However, with an evolving treatment landscape, CD38-targeted therapies have emerged as game-changers, offering hope for better prognosis